Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival
Abstract The atypical C-X-C chemokine receptor 7 (CXCR7) has been implicated in supporting aggressive cancer phenotypes in several cancers including prostate cancer. However, the mechanisms driving overexpression of this receptor in cancer are poorly understood. This study investigates the role of a...
Enregistré dans:
Auteurs principaux: | James J. Hoy, Georgios Kallifatidis, Diandra K. Smith, Bal L. Lokeshwar |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d694f9f3e8db41efa65a4e39eb7119d8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
FEATURES OF LOCAL mRNA SYNTHESIS FOR SOME CC- AND CXC-CHEMOKINES AND THEIR RECEPTORS IN ENDOMETRIAL HYPERPLASIA
par: N. V. Kipich, et autres
Publié: (2014) -
Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
par: Aasems Jacob, et autres
Publié: (2021) -
Androgen receptor-binding sites are highly mutated in prostate cancer
par: Tunç Morova, et autres
Publié: (2020) -
Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10
par: Weiyuan Li, et autres
Publié: (2021) -
Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival.
par: Emma Hörnberg, et autres
Publié: (2011)